Flavoxate Hydrochloride and Fluocinolone Acetonide topical

• Generic Name: flavoxate
• Dosage Forms: n.a.
• Other Brand Names: Urispas

Symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence associated with cystitis, prostatitis, urethritis, urethrocystitis, or urethrotrigonitis. Not indicated as definitive treatment, but is compatible with drugs used for treatment of urinary tract infections.

Has not been shown to be more effective in the treatment of these conditions than antimuscarinic agents.

• Generic Name: fluocinolone topical
• Dosage Forms: n.a.
• Other Brand Names: Capex, Flurosyn, Synalar, Synalar Ointment, Derma-Smoothe/FS

Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Generally most effective in acute or chronic dermatoses (e.g., seborrheic or atopic dermatitis, localized neurodermatitis, anogenital pruritus, psoriasis, late phase of allergic contact dermatitis, inflammatory phase of xerosis).

Topical therapy generally preferred over systemic therapy; fewer associated adverse systemic effects.

Topical therapy generally only controls manifestations of dermatoses; eliminate cause if possible.

Topical efficacy may be increased by using a higher concentration or occlusive dressing therapy. (See Administration with Occlusive Dressing under Dosage and Administration.)

Response may vary from one topical corticosteroid preparation to another.

Anti-inflammatory activity may vary considerably depending on the vehicle, drug concentration, site of application, disease, and individual patient.

Fluocinonide 0.05% cream, ointment, and gel are considered to have high-range potency.

Fluocinolone acetonide 0.025% ointment is considered to have high-range potency.

Fluocinolone acetonide 0.025% cream is considered to have medium potency.

Fluocinolone acetonide 0.01% shampoo is considered to have low–medium potency.

Fluocinolone acetonide 0.01% solution is considered to have low potency.